Search & Analyze

Eris Lifesciences Ltd.

1,150.00−13.70 (−1.18%)

BSE · 30 Oct, 4:01 PM

: ₹16,088.12 Cr
: 22.74
: 2,549
: ₹1,172.50 - ₹1,150.00
: ₹1,737.00 - ₹1,069.00

Eris Lifesciences Ltd. (ERIS) share price closed at ₹1,150.00 on the BSE on Friday, October 30, 2026, down by 1.18% from its of ₹1,163.70. In that session ERIS reached a of 1,172.50 and of 1,150.00. The for the session was 1,165.82. The stands at 1,242.41 and is at 1,350.97. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹1,155.40

₹1,163.70

₹1,165.82

₹1,242.41

Price 7.44% below

₹1,350.97

Price 14.88% below

Key Fundamentals

: 16,088.12 Cr₹16.09 Thousand Crore
: 51.00
: 22.74
: 3.88
: 298.72
: 1,168.59 Cr₹1.17 Thousand Crore
: 0.00 %
Sector
Industry: Pharmaceuticals & Drugs
: 19.23
: 0.59

Industry Comparison

Ratio	Company	Sector
	22.74	44.77
	0.59	0.20
	3.88	4.61
	0.76	1.81
	0.00 %	0.11 %
Operating Margin	34.09 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Eris Lifesciences Ltd. ERIS	1,150.00	22.74	16,088.12	0.00	187.14	39.17%	892.37	12.61%	14.47

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	550.93	719.72	741.17	727.45	705.30	773.00	792.41	807.45	756.56	873.25	892.37
Expenses	402.51	469.73	476.66	477.14	452.91	496.29	504.20	525.84	482.99	577.03	583.02
	148.42	249.99	264.51	250.31	252.39	276.71	288.21	281.61	273.57	296.22	309.35
	26.94%	34.73%	35.69%	34.41%	35.78%	35.80%	36.37%	34.88%	36.16%	33.92%	34.67%
	15.15	1.64	4.55	4.22	7.95	2.69	2.81	-17.22	2.23	2.39	39.10
Interest	33.03	60.37	59.47	57.17	54.28	48.68	49.55	48.82	45.62	46.65	46.42
	53.80	75.74	80.38	81.00	77.25	70.51	69.08	70.34	69.57	72.07	73.42
	76.74	115.52	129.21	116.36	128.87	161.10	172.67	145.35	159.41	179.49	155.91
	-3.86%	22.48%	25.39%	25.18%	20.58%	22.35%	22.12%	25.13%	-75.08%	20.15%	-20.03%
	71.03	83.31	91.65	83.76	93.84	117.99	120.19	99.72	281.61	142.39	183.82
	5.22	6.12	6.73	6.15	6.89	8.66	8.82	7.32	20.33	10.27	13.25

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	1,394.96	1,765.16	2,114.56	2,972.84	3,254.22
	1,347.04	1,685.15	2,009.15	2,893.64	3,129.42
EXPENDITURE :
Increase/Decrease in Stock	-0.78	3.82	0.72	-35.47	-21.61
Raw Material Consumed	259.29	348.53	379.33	749.46	817.21
Power & Fuel Cost	4.16	5.70	12.04	15.08	12.90
Employee Cost	250.18	346.16	403.82	505.09	556.81
Other Manufacturing Expenses	38.81	15.61	23.89	47.18	56.13
General and Administration Expenses	154.21	206.62	253.91	261.45	291.67
Selling and Distribution Expenses	121.39	185.17	208.45	289.47	253.51
Miscellaneous Expenses	34.74	36.80	52.16	44.18	53.39
	862.02	1,148.40	1,334.32	1,876.44	2,020.01
Operating Profit (Excl OI)	485.03	536.75	674.83	1,017.20	1,109.41
	26.09	11.15	23.82	18.36	18.45
	511.12	547.90	698.65	1,035.56	1,127.86
Interest	4.22	26.17	84.80	231.29	192.67
PBDT	506.90	521.73	613.85	804.27	935.19
	64.71	117.09	182.51	315.46	279.50
Profit Before Taxation & Exceptional Items	442.20	404.64	431.34	488.81	655.69
Exceptional Income / Expenses					-17.24
	442.20	404.64	431.34	488.87	638.54
Provision for Tax	36.41	30.48	34.22	114.20	-8.97
	405.79	374.16	397.12	374.67	647.51
Extra items				0.00	0.00
Minority Interest	0.32	8.00	-5.07	-22.83	-27.99
Consolidated Net Profit	406.11	382.16	392.05	351.84	619.52
Profit Balance B/F	1,550.31	1,873.65	2,155.93	2,540.94	2,792.76
Appropriations	1,956.43	2,255.81	2,547.98	2,892.78	3,412.28
Equity Dividend %	601.00%	735.00%		735.00%
	29.88	28.10	28.83	25.83	44.73
Adjusted EPS	29.88	28.10	28.83	25.83	44.73

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	13.59	13.60	13.60	13.62	13.85
Share Warrants & Outstandings	1.90	2.80	5.02	10.09	14.26
Total Reserves	1,892.82	2,179.59	2,567.56	2,830.65	3,874.56
Reserve excluding Revaluation Reserve	1,892.82	2,179.59	2,567.56	2,830.65	3,874.56
Revaluation reserve				0.00
	1,908.31	2,195.99	2,586.18	2,854.36	3,902.67
Minority Interest	-0.11	24.69	635.91	417.40	-7.01
Secured Loans	45.00	644.45	654.51	1,737.51	955.83
Deferred Tax Assets / Liabilities	-197.04	-16.31	227.44	229.41	62.17
Other Long Term Liabilities	41.08	57.21	44.68	55.08	45.06
Long Term Provisions	32.16	44.67	52.72	78.97	86.78
Total Non-Current Liabilities	-78.80	730.02	979.35	2,100.97	1,149.84
Trade Payables	117.77	124.77	218.93	332.35	329.65
Other Current Liabilities	35.81	190.12	900.18	533.99	1,178.05
Short Term Borrowings	0.01	55.01	1,311.31	396.59	453.93
Short Term Provisions	129.75	151.29	178.54	229.86	239.59
Total Current Liabilities	283.34	521.19	2,608.96	1,492.79	2,201.22
Total Liabilities	2,112.74	3,471.88	6,810.40	6,865.52	7,246.72
Gross Block	1,091.96	2,843.17	4,772.87	6,060.84	6,161.55
Less: Accumulated Depreciation	174.02	275.07	453.71	754.36	973.99
	917.94	2,568.10	4,319.16	5,306.48	5,187.56
	24.00	21.38	19.06	66.74	171.47
Non Current Investments	420.84	6.69	15.55	62.00	61.56
Long Term Investment	420.84	6.69	15.55	62.00	61.56
Long Term Loans & Advances	35.94	25.32	69.83	88.29	151.73
Other Non Current Assets		7.37	7.26	7.35	10.43
Total Non-Current Assets	1,401.72	2,629.21	4,431.47	5,531.13	5,582.75
Currents Investments	99.55	30.01		5.00
Inventories	117.91	131.44	189.03	334.83	436.82
Sundry Debtors	160.97	292.71	422.00	458.64	680.34
Cash and Bank	52.33	58.46	1,400.64	222.83	67.30
Other Current Assets	24.04	22.42	32.14	25.81	44.04
Short Term Loans and Advances	256.23	307.65	335.12	287.28	435.47
Total Current Assets	711.03	842.67	2,378.93	1,334.39	1,663.97
Net Current Assets (Including Current Investments)	427.68	321.49	-230.03	-158.40	-537.25
Total Assets	2,112.74	3,471.88	6,810.40	6,865.52	7,246.72
	24.51	28.39	53.95	51.96	51.57
Total Debt	45.01	830.02	2,735.27	2,421.66	2,309.68
	140.25	161.28	189.79	208.83	280.75
Adjusted Book Value	140.25	161.28	189.79	208.83	280.75

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	442.20	404.64	431.34	488.87	638.54
Adjustment	49.25	139.84	254.16	548.05	481.86
Changes In working Capital	-29.90	-175.54	-98.74	125.97	-458.03
Cash Flow after changes in Working Capital	461.55	368.95	586.76	1,162.89	662.37
Cash Flow from Operating Activities	378.26	291.74	486.01	1,065.01	537.99
Cash Flow from Investing Activities	-319.61	-982.10	-1,854.52	-79.97	-369.46
Cash Flow from Financing Activitie	-44.70	688.03	1,379.68	-881.32	-313.53
Net Cash Inflow / Outflow	13.96	-2.34	11.17	103.72	-145.00
Opening Cash & Cash Equivalents	36.92	50.87	56.02	94.25	199.74
Cash & Cash Equivalent on Amalgamation / Take over / Merger		7.49	26.96	1.77
Closing Cash & Cash Equivalent	50.87	56.02	94.15	199.74	54.74

Ratios

Valuation

22.74

3.88

15.59

4.86

51.00

298.72

Profitability

19.23

14.47

9.18

34.09

19.90

Leverage & Liquidity

0.59

0.76

4.31

Returns

0.00

0.46

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	54.88	54.87	54.86	54.85	54.83	54.85	54.85	53.92	54.14	54.74
	30.82	26.64	26.41	26.50	26.57	26.57	27.17	26.74	26.47	25.94
	14.30	18.47	18.72	18.66	18.59	18.57	17.99	19.33	19.40	19.32
	45.12	45.13	45.14	45.15	45.17	45.15	45.15	46.08	45.86	45.26
No. of Shareholders	44,176	46,346	53,314	50,087	52,225	59,438	54,713	51,656	50,798	49,034

Mutual Funds Invested(62)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 50 active funds hold 17.86% in Eris Lifesciences Ltd., contributing to ₹2.95K Cr of holdings

Fund				As of
HD HDFC Small Cap Fund - Growth - Direct PlanSmall cap Fund	770.52	1.89	64,64,629	Sep '26
HD HDFC Aggressive Hybrid Fund - Growth - Direct PlanHybrid - Aggressive Hybrid Fund	293.16	1.39	24,59,629	Sep '26
FT Franklin India Small Cap Fund - Growth - Direct PlanSmall cap Fund	285.16	2.00	23,92,469	Sep '26
FT Franklin India Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	169.00	0.93	14,17,881	Sep '26
DS DSP Small Cap Fund - Growth - Direct PlanSmall cap Fund	146.60	0.68	12,30,000	Sep '26
HS HSBC Small Cap Fund - Growth - Direct PlanSmall cap Fund	92.60	0.50	7,76,897	Sep '26
UT UTI Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	85.95	0.38	7,21,077	Sep '26
MI Mirae Asset Healthcare Fund - Growth - Direct PlanPharma & Health Care	83.38	2.39	6,99,590	Sep '26
HD HDFC Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	80.85	0.41	6,78,362	Sep '26
HD HDFC Large & Mid Cap Fund - Growth - Direct PlanLarge & Mid Cap	80.45	0.28	6,75,000	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-19	Board Meeting	Quarterly Results
2026-09-02	AGM
2026-07-23	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Eris Lifesciences Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Milind Talegaonkar

Company Secretary & Compliance Officer

—

Amit Indubhushan Bakshi

Chairman & Managing Director

₹4.88 Cr

Mar '26

Krishnakumar Vaidyanathan

Whole Time Director & COO

₹4.58 Cr

Mar '25

Inderjeet Singh Negi

Whole Time Director

₹1.24 Cr

Mar '26

Kaushal Shah

Whole Time Director

₹1.68 Cr

Mar '26

Sujesh Vasudevan

Non Executive Independent Director

₹44.25 L

Mar '26

Kalpana Unadkat

Non Executive Independent Director

₹47.25 L

Mar '26

Prashant Gupta

Non Executive Independent Director

₹81.00 L

Mar '26

Vineet Varma

Non Executive Independent Director

₹1.74 L

Mar '26

ERIS Latest News

News

5 of 5 articles

EQUITY31 Aug 2026 · 15:41

Eris Lifesciences informs about outcome of board meeting

EQUITY29 Jul 2026 · 14:52

Eris Lifesciences informs about outcome of board meeting

EQUITY23 Jul 2026 · 17:39

Eris Lifesciences informs about board meeting

EQUITY20 May 2026 · 14:43

Eris Lifesciences reports Profit after tax of Rs -86.00 Mln, in the March 2026 quarter

EQUITY11 May 2026 · 14:44

Eris Lifesciences informs about allotment of equity shares

Eris Lifesciences Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(62)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

ERIS Latest News

News